Menu Search
Equities

Pennant Group Inc

PNTG:NSQ

Pennant Group Inc

Actions
Health CareHealth Care Providers
  • Price (USD)33.65
  • Today's Change-0.18 / -0.53%
  • Shares traded227.78k
  • 1 Year change+171.59%
  • Beta1.9770
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Pennant Group Inc grew revenues 15.14% from 473.24m to 544.89m while net income improved 101.40% from 6.64m to 13.38m.
Gross margin20.55%
Net profit margin3.42%
Operating margin5.59%
Return on assets3.83%
Return on equity13.92%
Return on investment4.54%
More ▼

Cash flow in USDView more

In 2023, Pennant Group Inc increased its cash reserves by 191.44%, or 3.98m. The company earned 33.09m from its operations for a Cash Flow Margin of 6.07%. In addition the company generated 1.11m cash from financing while 30.22m was spent on investing.
Cash flow per share0.9103
Price/Cash flow per share41.58
Book value per share5.59
Tangible book value per share-1.84
More ▼

Balance sheet in USDView more

Pennant Group Inc has a Debt to Total Capital ratio of 36.76%, a lower figure than the previous year's 39.98%.
Current ratio1.12
Quick ratio--
Total debt/total equity0.6428
Total debt/total capital0.3676
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 101.17%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)-5.49
EPS (TTM) vs
TTM 1 year ago		65.93
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.